Cohen Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.42M Hold
8,143
– – 1.31% 23
2026
Q2
$9.77M Hold
8,143
– – 1.33% 24
2026
Q1
$7.49M Buy
8,143
+91
+1% +$92.3K 1.16% 27
2025
Q4
$8.65M Sell
8,052
-300
-4% -$287K 1.3% 24
2025
Q3
$6.37M Buy
8,352
+7,886
+1,692% +$5.87M 0.99% 29
2025
Q2
$363K Hold
466
– – 0.06% 129
2025
Q1
$385K Buy
466
+128
+38% +$107K 0.07% 124
2024
Q4
$261K Buy
338
+27
+9% +$22.4K 0.04% 137
2024
Q3
$276K Buy
+311
New +$280K 0.04% 140

Other funds holding LLY

Cohen Capital Management's LLY Position: Q3 2026 in Review

Cohen Capital Management held its Eli Lilly (LLY) position steady in Q3 2026 at 8,143 shares worth $9.42M. The position accounts for 1.31% of the portfolio, ranked #23.

Cohen Capital Management first reported a position in LLY in Q3 2024 and has held it in 9 quarters since. The position peaked at $9.77M in Q2 2026. 565 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Cohen Capital Management held 8,143 shares of Eli Lilly worth $9.42M as of Q3 2026.
  • Cohen Capital Management left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 1.31% of Cohen Capital Management's portfolio in Q3 2026, its #23 holding.
  • Cohen Capital Management first reported a position in Eli Lilly in Q3 2024 and has held it in 9 quarters since.
  • Cohen Capital Management's Eli Lilly position peaked at $9.77M in Q2 2026.
  • 565 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Cohen Capital Management's 13F filing for Q3 2026, filed 14 Oct 2026.